Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukemia in older patients not considered candidates...

Yazar: Amadori, Sergio, Suciu, Stefan, Selleslag, Dominik, Stasi, Roberto, Alimena, Giuliana, Baila, Liliana, Rizzoli, Vittorio, Borlenghi, Erika, Gaidano, Gianluca, Magro, Domenico, Torelli, Giuseppe, Muus, Petra, Venditti, Adriano, Cacciola, Emma, Lauria, Francesco, Vignetti, Marco, de Witte, Theo
Baskı/Yayın Bilgisi 2010